Drägerwerk AG & Co. KGaA (ETR:DRW3 - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €48.13 ($52.32) and traded as high as €56.50 ($61.41). Drägerwerk AG & Co. KGaA shares last traded at €55.00 ($59.78), with a volume of 9,673 shares trading hands.
Drägerwerk AG & Co. KGaA Price Performance
The business's 50-day simple moving average is €53.35 and its two-hundred day simple moving average is €48.35. The stock has a market cap of $1.01 billion, a price-to-earnings ratio of 9.55, a price-to-earnings-growth ratio of 1.24 and a beta of -0.31. The company has a debt-to-equity ratio of 20.57, a current ratio of 1.89 and a quick ratio of 0.81.
About Drägerwerk AG & Co. KGaA
(
Get Free Report)
Drägerwerk AG & Co KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.
See Also
Before you consider Drägerwerk AG & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Drägerwerk AG & Co. KGaA wasn't on the list.
While Drägerwerk AG & Co. KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
